4//SEC Filing
Chambers Michael 4
Accession 0001179110-13-000085
CIK 0001222244other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:16 PM ET
Size
18.7 KB
Accession
0001179110-13-000085
Insider Transaction Report
Form 4
Chambers Michael
Director
Transactions
- Exercise/Conversion
Warants
2012-12-28−10,000→ 0 totalExercise: $0.50Exp: 2012-12-31→ Common stock, $0.00001 par value (10,000 underlying) - Exercise/Conversion
Common Stock, $0.00001 par value
2012-12-28$1.10/sh+6,453$7,098→ 155,807 total - Exercise/Conversion
Common Stock, $0.00001 par value
2012-12-28$0.50/sh+10,000$5,000→ 165,807 total - Award
Common stock, $0.00001 par value
2012-12-28$0.64/sh+9,375$6,000→ 149,354 total - Exercise/Conversion
Convertible Note
2012-12-28−6,453Exercise: $1.10Exp: 2012-12-28→ Common stock, $0.00001 par value
Holdings
- 25,000
Stock Options
Exercise: $0.60Exp: 2017-08-09→ Common stock, $0.00001 par value (25,000 underlying) - 73,776
Warrants
Exercise: $1.30Exp: 2014-01-07→ Common stock, $0.00001 par value (73,776 underlying) - 28,736
Stock options
Exercise: $0.87Exp: 2018-08-09→ Common stock, $0.00001 par value (28,736 underlying) - 14,535
Options
Exercise: $1.72Exp: 2017-08-10→ Common stock, $0.00001 par value (14,535 underlying) - 10,374
Options
Exercise: $2.41Exp: 2017-03-01→ Common stock, $0.00001 par value (10,374 underlying)
Footnotes (5)
- [F1]Currently exercisable.
- [F2]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over 12 months.
- [F3]On December 28, 2012, the reporting person converted a convertible promissory note in the principal amount of $6,400, along with accrued interest thereon of $1,099, into common shares pursuant to the terms of the note. The transaction was approved by the Company's Board of Directors and is exempt under section 16b-3(d).
- [F4]Shares issued to directors in payment of directors' fees earned during the period from July 1, 2012 and December 31, 2012, in lieu of cash. The Issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rule 16b-3(d).
- [F5]Exercise of warrants at $0.50 per share.
Documents
Issuer
ProUroCare Medical Inc.
CIK 0001222244
Entity typeother
Related Parties
1- filerCIK 0001485975
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:16 PM ET
- Size
- 18.7 KB